ConductScience.org, home
A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients
API referenceFor AI assistants

Trial · NCT02135107

Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Treatment PeriodSTARTEDRabeprazole: 10 mg Twice Daily437
Treatment PeriodSTARTEDRabeprazole: 20 mg Twice Daily80
Treatment PeriodSTARTEDRabeprazole: 10 or 20 mg Twice Daily, Then 10 mg Once Daily0
Treatment PeriodSTARTEDRabeprazole: 10 or 20 mg Twice Daily, Then 10 mg Twice Daily0
Treatment PeriodCOMPLETEDRabeprazole: 10 mg Twice Daily305
Treatment PeriodCOMPLETEDRabeprazole: 20 mg Twice Daily54
Treatment PeriodCOMPLETEDRabeprazole: 10 or 20 mg Twice Daily, Then 10 mg Once Daily0
Treatment PeriodCOMPLETEDRabeprazole: 10 or 20 mg Twice Daily, Then 10 mg Twice Daily0
Treatment PeriodNOT COMPLETEDRabeprazole: 10 mg Twice Daily132
Treatment PeriodNOT COMPLETEDRabeprazole: 20 mg Twice Daily26
Treatment PeriodNOT COMPLETEDRabeprazole: 10 or 20 mg Twice Daily, Then 10 mg Once Daily0
Treatment PeriodNOT COMPLETEDRabeprazole: 10 or 20 mg Twice Daily, Then 10 mg Twice Daily0
Maintenance Therapy PeriodSTARTEDRabeprazole: 10 mg Twice Daily0
Maintenance Therapy PeriodSTARTEDRabeprazole: 20 mg Twice Daily0
Maintenance Therapy PeriodSTARTEDRabeprazole: 10 or 20 mg Twice Daily, Then 10 mg Once Daily178
Maintenance Therapy PeriodSTARTEDRabeprazole: 10 or 20 mg Twice Daily, Then 10 mg Twice Daily181
Maintenance Therapy PeriodCOMPLETEDRabeprazole: 10 mg Twice Daily0
Maintenance Therapy PeriodCOMPLETEDRabeprazole: 20 mg Twice Daily0
Maintenance Therapy PeriodCOMPLETEDRabeprazole: 10 or 20 mg Twice Daily, Then 10 mg Once Daily163
Maintenance Therapy PeriodCOMPLETEDRabeprazole: 10 or 20 mg Twice Daily, Then 10 mg Twice Daily161

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02135107/flow

API referenceFor AI assistants